Aciclovir News
Statistically Significant Phase IIb Clinical Results Of Transport's Drug/Device Combination Product For Herpes Labialis
The results of this proof-of-concept Phase IIb trial demonstrated a one and a half day (or 35 hours) reduction in the intent-to-treat population median time to healing in the active treatment group as compared to the placebo...
Treatment with intravenous and oral antiviral medications may help relieve nerve pain related to shingles
A small trial suggests that treatment with intravenous and oral antiviral medications may reduce the nerve pain that occurs following shingles, according to a study posted online today that will appear in the July 2006 print...
Biovail Acquires Rights to Controlled Release Acyclovir -Genvir- from Flamel Technologies
Phase III Clinical Trials Set to Begin in The U.S. In the Second Half Of 2003
New Anti-Herpes Compounds Developed After 30 Years
The herpes simplex virus (HSV) is responsible for the cold sores and genital herpes that plague a great many people.
Common Anti-Viral Medication Prevents Severe Eye Herpes
A new study led by University of California San Francisco researchers has found that acyclovir, a common anti-viral drug used to treat and prevent genital herpes, can also prevent the recurrence of herpes disease of the eye.
Displaying results 6 to 10 out of 10